Home
About
Overview
Sharing Data
ORCID
Help
History (4)
Management of Latent Tuberculosis Infection.
Municipal Officials' Participation in Built Environment Policy Development in the United States.
Structural basis of Blastomyces Endoglucanase-2 adjuvancy in anti-fungal and -viral immunity.
The Patient Safety Screener: Validation of a Brief Suicide Risk Screener for Emergency Department Settings.
See All 4 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Management of Latent Tuberculosis Infection.
Kim S, Thal R, Szkwarko D. Management of Latent Tuberculosis Infection. JAMA. 2023 02 07; 329(5):421-422.
View in:
PubMed
subject areas
Antitubercular Agents
Humans
Latent Tuberculosis
Mycobacterium tuberculosis
authors with profiles
Daria Lesia Szkwarko DO
Rebecca Thal MSN, FNP-C, AAHIVS